Whitney et al24 prospectively validated a biomarker-based risk model8 consisting of patient age, C-C chemokine ligand 3, heat shock protein family A member 1B, and IL-8 to predict mortality-risk in pediatric ARDS. This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.